000 01408 a2200445 4500
005 20250516031838.0
264 0 _c20110830
008 201108s 0 0 eng d
022 _a2152-2669
024 7 _a10.3816/CLML.2011.n.027
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRicci, F
245 0 0 _aThe impact of advanced age according to IPSSWM cut-off on the outcome of symptomatic and asymptomatic Waldenström's macroglobulinemia at diagnosis.
_h[electronic resource]
260 _bClinical lymphoma, myeloma & leukemia
_cFeb 2011
300 _a124-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAge Factors
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPrognosis
650 0 4 _aRetrospective Studies
650 0 4 _aSurvival Rate
650 0 4 _aTreatment Outcome
650 0 4 _aWaldenstrom Macroglobulinemia
_xdiagnosis
700 1 _aTedeschi, A
700 1 _aVismara, E
700 1 _aGreco, A
700 1 _aMontillo, M
700 1 _aNichelatti, M
700 1 _aVarettoni, M
700 1 _aLazzarino, M
700 1 _aMorra, E
773 0 _tClinical lymphoma, myeloma & leukemia
_gvol. 11
_gno. 1
_gp. 124-6
856 4 0 _uhttps://doi.org/10.3816/CLML.2011.n.027
_zAvailable from publisher's website
999 _c20722730
_d20722730